3

OWNERSHIP DOCUMENT

Company: Protalix BioTherapeutics, Inc.
Filed: September 24, 2019
Period of Report: September 22, 2019
Accession Number: 0001144204-19-045805

View Document ↗ View on SEC.gov ↗